Imbalance of plasminogen activators and their inhibitors in human colorectal neoplasia. Implications of urokinase in colorectal carcinogenesis

  • 0Department of Gastroenterology and Hepatology, University Hospital, Leiden, The Netherlands.

|

|

Summary

This summary is machine-generated.

Colorectal cancer growth involves increased urokinase-type plasminogen activator (u-PA) and decreased tissue-type plasminogen activator (t-PA). Inhibitors PAI-1 and PAI-2 rise, but u-PA remains elevated, favoring tumor spread.

Area Of Science

  • Biochemistry
  • Oncology
  • Molecular Biology

Background

  • Adenocarcinomas exhibit altered plasminogen activator (PA) activity, with increased urokinase-type (u-PA) and decreased tissue-type (t-PA).
  • Plasminogen activator inhibitors (PAIs) like PAI-1 and PAI-2 play regulatory roles in PA activity.

Purpose Of The Study

  • To investigate the levels and activity of u-PA, t-PA, PAI-1, and PAI-2 in normal colon mucosa, adenomatous polyps, and adenocarcinomas.
  • To elucidate the role of these components in the progression of colonic neoplasia.

Main Methods

  • Enzymatic assays and zymography were used to determine PA activity.
  • Antigen levels of u-PA, t-PA, PAI-1, and PAI-2 were quantified.
  • Comparisons were made between normal mucosa, adenomas, and carcinomas.

Main Results

  • t-PA activity significantly decreased in neoplastic tissues, correlating with increased PAI-1 and PAI-2, especially in carcinomas.
  • u-PA antigen levels and activity were significantly elevated in neoplastic tissues, despite higher inhibitor concentrations.
  • Adenomatous polyps showed similar trends, suggesting early malignant potential.

Conclusions

  • PAI-1 and PAI-2 significantly contribute to the reduction of t-PA activity in colonic carcinomas.
  • Elevated u-PA in colonic neoplasia appears independent of PA inhibitor levels.
  • An imbalance favoring u-PA in colonic neoplasia may promote tumor growth, invasion, and metastasis.

Related Concept Videos